Faricimab CAS#: 1607793-29-2; ChemWhat Code: 1417436
Identification
| Product Name | Faricimab |
| IUPAC Name | |
| CAS Registry Number | 1607793-29-2 |
| Molecular Formula | |
| Molecular Weight | |
| InChI | |
| InChI Key | |
| Canonical SMILES |
Physical Data
No data available
Spectra
No data available
Route of Synthesis (ROS)
No data available
Safety and Hazards
No data available
Other Data
No data available
| Use Pattern |
| Faricimab CAS#: 1607793-29-2 is a bispecific antibody that is promising for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME). It simultaneously targets and blocks two key pathogenic pathways – angiopoietin-2 (Ang). -2) and vascular endothelial growth factor-A (VEGF-A), two pathways that drive many retinal diseases that lead to vision loss by destabilizing blood vessels. mRNAs. |
Buy Reagent | |
| No reagent supplier? | Send quick inquiry to ChemWhat |
| Want to be listed here as a reagent supplier? (Paid service) | Click here to contact ChemWhat |
Approved Manufacturers | |
| Watson Bio Ltd | https://www.watson-bio.com/ |
| Want to be listed as an approved manufacturer (Requires approvement)? | Please download and fill out this form and send back to approved-manufacturers@chemwhat.com |
Contact Us for Other Help | |
| Contact us for other information or services | Click here to contact ChemWhat |